14h
Zacks Investment Research on MSNVKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss DrugViking Therapeutics VKTX announced that it has completed enrolling study participants in the phase II VENTURE-Oral Dosing ...
Company announcement - No. 7 / 2025 Resolutions from Zealand Pharma's Annual General Meeting 2025 Copenhagen, Denmark, March 27, 2025 - Zealand Pharma A/S ("Zealand") (Nasdaq: ZEAL) (CVR-no. 20045078) ...
The global anti-inflammatory therapeutics market size was US$ 94,511 million in 2021. The global anti-inflammatory therapeutics market is forecast to grow to US$ 130,711.1 million by 2030 by ...
Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results